Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have to disagree with that. Each approved indication has it's own merit. BIEL could be profitable with just the knee or foot indication, not to mention the massive opportunity in RecoveryRX. Dr. Scholls just taking over the foot indication would have given us the legitimacy we are so sorely lacking. The complete lack of any follow through is the issue, not lacking the full clearance for musculoskeletal pain. IMO of course.
Kelly named herself CEO!?! GASP! What a shock. I hope the F she stays the hell out of the way and let's deals get done. Putting an SEC slapped person in charge isn't great for the horrid reputation of the company. The good: Keith didn't jump ship. Since he came onboard, the big names at least in the room have been amazing considering the size of BIEL. DR. Staelin is going to be involved. There is a BOD. I'd like to see the BOD enlarged a bit with some outside people, like maybe some large shareholders.
2-1 probably should have been even money.
Also, in many cases the larger company will rollout or make the announcement first. They do the leading.
I like the feel of this update more than past ones. Possibly seeing CE mark restoration before the end of the year would be a great Christmas present in my book. A change in culture is much needed. It starts with no glaring typos in shareholder updates. I'd like to see a website that is up to date. When people look for information, online is the first look people will likely have. As they say, "You don't get a second chance to make a first impression. A quick deal with Dr. Scholls (If that is who they talked to)would be be the fire starter. That would be a marketed product with with an established world leader. IMO, that is the smallest market as an indication. Even if the margins were low, it would be worth it for the legitimization effect to the product line.
I think the twice a month update thing will be stopped. Yes, i want info but, an update every two weeks is kind of silly and amateurish.
There should be PR's when there are things to PR and maybe put out an update quarterly like a faux CC. Now, PR the dang CEO so we can start to put the past behind us and move forward.